American Gastroenterological Association

AGA Application Management System Welcome to AGA’s online application portal. Please review the links below to start a new application, preview an application, or view a request for applications. Use the left navigation menu to access in-progress or previously submitted applications and any application review assignments. Do you want to return to an application you started or completed? In the navigation menu on the left, click on My Applications. 2025 AGA Abstract Awards (Applications close February 20,

Read the full article here

Source: agaawards.secure-platform.com

Categories: Gastroenterology, General Medicine News

Tags: TechSummit

Tweets with this article

AGA

Are you a GI startup or innovator? Apply to the Shark Tank Competition for the chance to showcase your innovation to investors and industry leaders at AGA Tech Summit! Apply by Feb. 10. Finalists will present at #TechSummit, April 3-4 in Chicago. https://t.co/9jmNt2FG9d https://t.co/2dxp8AOJkT

Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy – a multi-arm randomised controlled trial (HELIOS)

Background It remains unclear if the increased colorectal neoplasia detection rate in inflammatory bowel disease (IBD) by high-definition (HD) dye-based chromoendoscopy compared with HD white-light…

Gut Journal February 5, 2025

Detection of large flat colorectal lesions by artificial intelligence: a persistent weakness and blind spot

Computer-aided detection (CADe) has increased adenoma detection in randomised trials. However, unlike other detection adjuncts, CADe is lesion specific, that is, it is trained on…

Gut Journal February 5, 2025

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a 5-year survival rate of 12%. It has two major molecular subtypes: classical and…

Gut Journal February 5, 2025

Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+ myeloid cells to promote liver cancer progression

Objective The metabolic characteristics of liver cancer drive considerable hurdles to immune cells function and cancer immunotherapy. However, how metabolic reprograming in the tumour microenvironment…

Gut Journal February 5, 2025

A single-center pilot study on the efficacy and safety of acetic acid–enhanced magnifying endoscopy with narrow-band imaging for diagnosis of colorectal epithelial neoplasms

Post written by Takeshi Shimizu, MD, from the Department of Gastroenterology, Sendai City Medical Center, Sendai, Japan. The focus of our study was to identify the ideal…

GIE February 5, 2025

Related Articles